Updates on the Topamax Litigation

Reg Reinoso

Author

July 2024 Topamax Case Update from Attorney Mikal Watts

Mikal Watts of Watts Law Firm LLP continues to represent families in the ongoing Topamax litigation, focusing on the link between the drug and neurodevelopmental disorders in children born to women who took Topamax during pregnancy. This litigation requires extensive and precise documentation to substantiate claims effectively.

We are currently in a crucial phase of gathering necessary evidence. Clients are reminded to submit all relevant documentation, including medical records from obstetricians, birth records, pharmacy records for Topamax prescriptions, and records documenting diagnoses of Autism Spectrum Disorder, Intellectual Disability, or SD in their children. This information is critical in strengthening your claim and ensuring that your case is thoroughly prepared.

The urgency of submitting this information cannot be overstated. Delays in providing these documents can significantly hinder the progress of your claim. We urge all clients to ensure that their contact details, as well as those of their spouses and heirs, are up to date to facilitate effective communication throughout the litigation process.

We appreciate your trust and cooperation as we navigate this complex litigation. Our commitment to securing justice for affected families remains steadfast.

Background: The Concerns Over Topamax

Between 2003 and 2009, Topamax was extensively prescribed for seizure control and migraine prevention, widely trusted by healthcare professionals and pregnant women. However, emerging research has linked prenatal exposure to Topamax to an increased risk of Autism Spectrum Disorder (ASD) and intellectual disabilities in children, raising serious concerns about the drug’s safety during pregnancy.

The FDA has issued warnings regarding the use of Topamax during pregnancy, particularly concerning the risk of cleft lip and palate in newborns. Despite these warnings, the broader potential risks involving neurodevelopmental disorders have only recently come to light, prompting legal action and a reevaluation of the drug’s safety profile.

Empowering Families Through Legal Advocacy

Watts Law Firm LLP is at the forefront of this litigation, advocating for the rights of families affected by Topamax. The firm’s efforts not only seek compensation for the families but also aim to drive changes in pharmaceutical safety standards to prevent similar issues in the future.

Legal advocacy serves as a powerful tool to support families dealing with the challenges of raising children with ASD or intellectual disabilities, providing them with the means to access necessary care and therapies. Through these legal actions, Watts Law Firm LLP strives to enhance transparency and accountability in the pharmaceutical industry, ensuring better protection for all patients.

For further information or to discuss your case, please contact Watts Law Firm LLP directly. We are here to help and guide you through each step of this important legal process.